Vcheck Canine TnI Test

Supplied By: Bionote USA Inc (VCF137DC)


SKU
080646


Unit of
Measure
5 Count


Pack
Type
Box


Case
Qty
1

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Jun- 2026 May- 2026 Apr- 2026 Mar- 2026 Feb- 2026 Jan- 2026 Dec- 2025 Nov- 2025 Oct- 2025 Sep- 2025 Aug- 2025 Jul- 2025 Jun- 2025
{{purchaseHistoryItem}}


SKU
080646


Size
5 Count

Case
Qty
1

Purchase History

Jun- 2026 {{productPurchaseHistory['080646'][0]}} Nov- 2025 {{productPurchaseHistory['080646'][0+7]}}
May- 2026 {{productPurchaseHistory['080646'][1]}} Oct- 2025 {{productPurchaseHistory['080646'][1+7]}}
Apr- 2026 {{productPurchaseHistory['080646'][2]}} Sep- 2025 {{productPurchaseHistory['080646'][2+7]}}
Mar- 2026 {{productPurchaseHistory['080646'][3]}} Aug- 2025 {{productPurchaseHistory['080646'][3+7]}}
Feb- 2026 {{productPurchaseHistory['080646'][4]}} Jul- 2025 {{productPurchaseHistory['080646'][4+7]}}
Jan- 2026 {{productPurchaseHistory['080646'][5]}} Jun- 2025 {{productPurchaseHistory['080646'][5+7]}}
Dec- 2025 {{productPurchaseHistory['080646'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

The Vcheck TnI biomarker is an in vitro diagnostic test kit for the in-clinic quantitative measurement of canine troponin I (TnI). The cardiac troponin I, is a sensitive and specific circulating marker of cardiac damage in canines. Included in the greater troponin complex, troponin I, T, and C, function together as the molecular switch of cardiomyocyte contraction. Cardiac injury leads to the release of cardiac TnI into circulation, where its concentration correlates with the degree of cardiac damage. Heart disease can increase the TnI levels and create ongoing myocardial injury, so frequent monitoring is critical. This test must be used with the V200 (SKU 080946).

Features & Benefits

  • Increased TnI indicates rising severity of mitral valve disease (MMVD)
  • Detects early phases of dilated cardiomyopathy (DCM)
  • Provides prognostic information regardless of the underlying cardiac or noncardiac disease